digzyme Inc.

digzyme Inc.

Private
TokyoHealthcare & Life Scienceshttps://www.digzyme.com/

Last Round

Series A

Apr 23, 2024

Total Funding Raised

$6.36M

Company Overview

digzyme Inc. is a biotechnology company that has developed a platform for enzyme development using bioinformatics and in silico design.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, ML Platforms, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Revenue Share, Government Contracts

AI Layer

Application

Keywords

enzyme development platformenzyme engineeringenzyme discoverybioinformatics platformprotein engineeringsynthetic biologysynbiocustom biocatalystsAI for biologycustom enzyme librarybiocatalysisindustrial enzymesbiomanufacturingcomputational biologynon-GM enzymes

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

digzyme Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

digzyme Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AApr 23, 2024
Pre SeedJul 30, 2021
SeedMay 29, 2020

Key People

Founding team and executive leadership

Naoki Watarai

CEO

Executive Team

Kazuki K.

CFO

Executive Team

digzyme Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 25, 2026

    Grew 43% QoQ, from 7 to 10 employees.

  • Aug 25, 2025

    Grew 133% QoQ, from 3 to 7 employees.

digzyme Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

digzyme Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about digzyme Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range10
Year Founded2019
Last FundingApr 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.